期刊文献+

降钙素原和超敏C反应蛋白检测在慢性阻塞性肺疾病急性加重中的意义 被引量:14

Clinical significance of detection of serum procalcitonin and high-sensitivity C-reactive protein in AECOPD
暂未订购
导出
摘要 目的探讨检测血清降钙素原(PCT)、超敏C反应蛋白(hs-CRP)、白细胞计数(WBC)在慢性阻塞性肺疾病急性加重(AECOPD)患者诊疗中的意义。方法选择45例AECOPD患者(AECOPD组)及50例慢性阻塞性肺疾病(COPD)稳定期患者(COPD组),分别测定其PCT、hs-CRP和WBC。结果治疗前AECOPD组的PCT、hs-CRP分别为(3.32±1.81)ng/mL和(22.36±5.03)mg/L,明显高于COPD组,差异有统计学意义(P<0.01)。AECOPD组的PCT、hs-CRP阳性率诊断为68.9%和60.0%,均高于COPD组,差异有统计学意义(P<0.01)。AECOPD患者经抗菌药物治疗后PCT、hs-CRP、WBC较治疗前显著降低,差异有统计学意义(P<0.01)。结论在AECOPD患者中,PCT和hs-CRP是较好的诊断指标。 Objective To evaluate the clinical significance of detection of serum procalcitonin(PCT),high sensitivity-C-reactive protein(hs-CRP)and leukocyte in acute exacerbation of chronic obstructive pulmonary disease(AECOPD)patients.Methods 45 patients with AECOPD and 50 patients(AECOPD group)with chronic obstructive pulmonary disease(COPD)in slationary phase (COPD group)were selected,and their serum levels of PCT,hs-CRP and leukocyte were tested.Results Before treatment,the con-centrations of PCT and hs-CRP were (3.32±1.81)ng/mL and (22.36±5.03)mg/L in AECOPD group respectively.They were significantly higher than those in COPD group with statistical differences(P〈0.01).The positive predictive value of PCT and hs-CRP was 68.9% and 60.0% in AECOPD group respectively,which were significantly higher than those in COPD group(P〈0.01).After antibiotic treatment,the leukocyte,PCT,and hs-CRP levels in AECOPD group were significantly lower than those be-fore treatment(P〈 0.01).Conclusion In AECOPD patients,PCT and hs-CRP are good diagnostic indexes.
出处 《国际检验医学杂志》 CAS 2014年第12期1573-1574,共2页 International Journal of Laboratory Medicine
关键词 降钙素原 C反应蛋白 慢性阻塞性肺病 细菌感染 procalcitonin C reactive protein chronic obstructive pulmonary disease bacterial infection
  • 相关文献

参考文献15

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8251
  • 2Stockley RA. Progression of chronic obstructive pulmonary dis- ease:impact of inflammation, comorbidities and therapeutic inter vention[J]. Curr Med Res Opin, 2009,25(5) :1235- 1245.
  • 3Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pul- monary disease[J]. Transl Res, 2012,159 (4) : 228-237.
  • 4张敏,冯志顺,邓哲彤,叶小玲,张锐,晋金兰,余让辉.血清降钙素原和C反应蛋白检测在脓毒症早期诊断中的意义[J].广东医学,2011,32(17):2260-2262. 被引量:50
  • 5唐学义,郑素歌,杨志刚.COPD患者急性加重期血清降钙素原水平的变化及临床意义[J].医药论坛杂志,2010,31(13):119-121. 被引量:7
  • 6李俊,陈弘群,蒋世峰,谢骏,余荣环,曲毅.血清降钙素原和超敏C-反应蛋白在AECOPD的作用[J].临床肺科杂志,2012,17(8):1368-1370. 被引量:41
  • 7Daniels JM,Schoorl M,Snijders D, et al. Procalcitonin vs C-reac tire protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD[J]. Chest, 2010, 138 (5):1108- 1115.
  • 8Pazarli AC, Koseoglu HI, Doruk S, et al. Procalcitonin: is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation? [J]. J Res Med Sci,2012,17(11):1047-1051.
  • 9Albrich WC,Dusemund F,Bucher B,et al. Effectiveness and safe- ty of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter posts tudy survey (ProREAL)[J]. Arch Intern Med,2012,172(9) :715 - 722.
  • 10Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibi- otic use vs a standard approach for acute respiratory tract infec tions in primary eare[J]. Arch Intern Med, 2008,168 (18) : 2000- 2007.

二级参考文献28

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:280
  • 2常春,姚婉贞,陈亚红,刘振英,张晓伟.血清降钙素原对慢性阻塞性肺疾病加重期患者下呼吸道细菌感染的诊断价值[J].北京大学学报(医学版),2006,38(4):389-392. 被引量:50
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8251
  • 4Gendrel D, Bohuon C. Procalctonin as a marker of bacterial infection, bacterial infection [ J ]. Pediatr Infect Dis J ,2000,19:679-688.
  • 5Van der Valk P, Monninkhof E, van der Palen J, et al. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease [ J]. Clin Infect Dis,2004,39:980-986.
  • 6Pavord ID, Pizzichini MM, Pizzichini E, et al. The use of induced sputum to investigate airway inflammation [ J ]. Thorax, 1997,52:498-501.
  • 7Pye A, Stockley RA, Hill SL. Simple method for quantifying viable bacterial numbers in sputum [ J ]. J Clin Pathol, 1995,48:719-724.
  • 8Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease [ J ]. Ann Inten Med, 1987, 106: 196- 204.
  • 9Polzin A,Pletz M,Erbes R, et al. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis [ J ]. Eur Respir J ,2003,21 : 939-943.
  • 10Christ - Crain M, Jaccard - Stolz D, Bingisser R, et al. Effect of procalcitonin - guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster - randomised. Single - blinded intervention trial [ J ]. Lancet,2004,363 : 600-607.

共引文献8332

同被引文献98

引证文献14

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部